Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page shows a revision from v3.6.0 to v3.6.2. This appears to be a minor update to the ClinicalTrials.gov page, likely including small fixes or UI tweaks without changing study details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check18 days agoChange DetectedRecruitment status is updated to indicate no further participant enrollment. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, and the Intervention/Treatment label is updated while older labels and revision text are removed.SummaryDifference0.5%

- Check26 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a minor update to the page version. No substantive study information appears to be altered.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 on the page, indicating a minor update to the page metadata.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page’s footer/version indicator was updated from revision v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the clinical study information.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision version updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.